Crystal structure of 2-[[4-[2-[4-(4-methoxyphenyl)-1-piperazinyl]ethyl]phenyl]methyl]-1H-isoindole-1,3(2H)-dione, C28H29N3O3

被引：1
|
作者：
Zhou, Jinhui [1 ,2 ]
Huang, Cuicui [3 ]
Shi, Maojian [1 ]
Liu, Jing [1 ]
Ding, Lin [1 ]
机构：
[1] Jining Med Univ, Coll Pharm, Rizhao 276826, Shandong, Peoples R China
[2] Univ Shandong, Sch Chem & Chem Engn, Jinan 250100, Shandong, Peoples R China
[3] Zaozhuang Vocat Coll Sci & Technol, Dept Med Technol, Tengzhou 277599, Shandong, Peoples R China
来源：
ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES | 2018年 / 233卷 / 04期
关键词：
D O I：
10.1515/ncrs-2018-0034
中图分类号：
O7 [晶体学];
学科分类号：
0702 ; 070205 ; 0703 ; 080501 ;
摘要：
C28H29N3O3, triclinic, P (1) over bar (no. 2), a = 8.2887(3) angstrom, b = 14.1977(5) angstrom, c = 21.3385(7) angstrom, alpha = 107.142(3)degrees, beta = 92.773(3)degrees, gamma =104.240(3)degrees, V = 2305.97(15) angstrom(3), Z = 4, R-gt(F-2) = 0.0555, wR(ref)(F-2) = 0.1620, T = 100(1) K.
引用
收藏
页码：711 / 714
页数：4
相关论文
共 50 条
  • [21] AN IMPROVED SYNTHESIS OF (E)-2-(4-HYDROXY-3-METHYL-2-BUTENYL)-1H-ISOINDOLE-1,3(2H)-DIONE - A KEY TRANS-ZEATIN INTERMEDIATE
    GRAY, GM
    SYNTHESIS-STUTTGART, 1983, (06): : 488 - 489
  • [22] Halocyclization of 2-(2-{4-[allylamino(thioxo)methyl]piperazin-1-yl}ethyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione
    Yu. L. Zborovskii
    V. V. Orysyk
    V. I. Staninets
    V. V. Bon’
    Russian Journal of Organic Chemistry, 2011, 47 : 881 - 885
  • [23] Halocyclization of 2-(2-{4-[allylamino(thioxo)methyl]piperazin-1-yl}ethyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione
    Zborovskii, Yu. L.
    Orysyk, V. V.
    Staninets, V. I.
    Bon', V. V.
    RUSSIAN JOURNAL OF ORGANIC CHEMISTRY, 2011, 47 (06) : 881 - 885
  • [24] Crystal structure of 1-[2-[6-(4-methoxyphenyl)-3(2H)-pyridazinone-2-yl]acetyl]-4-(3-chlorophenyl)piperazine, C23H23ClN4O3
    Ingeç, SK
    Soylu, H
    Engin, K
    Dogruer, DS
    Sahin, MF
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2000, 215 (03): : 433 - 434
  • [25] CARDIOVASCULAR EFFECT OF A NOVEL SUBSTANCE, 3-[2-[4-(O-METHOXYPHENYL)-1-PIPERAZINYL]ETHYL]-2,4(1H,3H)-QUINA-ZOLINEMONOHYDROCHLORIDE(SGB 1534)
    UCHIDA, Y
    SUGIMOTO, T
    JAPANESE JOURNAL OF PHARMACOLOGY, 1984, 36 : P280 - P280
  • [26] Crystal structure of 2-((3-(5-methyl-1-phenyl-1H-1,2,3-triazol-4-yl)-1-phenyl-1H-pyrazol-4-yl)methylene)-1H-indene-1,3(2H)-dione, C28H19N5O2
    El-Hiti, Gamal A.
    Abdel-Wahab, Bakr F.
    Hegazy, Amany S.
    Alamri, Mesfer
    Kariuki, Benson M.
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2017, 232 (01): : 19 - 20
  • [27] STRUCTURE OF 2-(4-METHYLPHENYL)-1H-INDENE-1,3(2H)-DIONE
    KOLEV, T
    PREUT, H
    BLECKMANN, P
    JUCHNOVSKI, I
    ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1992, 48 : 1547 - 1549
  • [28] CARDIOVASCULAR EFFECT OF A NOVEL SUBSTANCE, 3-[2-[4-(0-METHOXYPHENYL)-1-PIPERAZINYL] ETHYL]-2,4(1H, 3H)-QUINAZOLINEDIONE MONOHYDROCHLORIDE(SGB 1534)
    UCHIDA, Y
    SUGIMOTO, T
    FOLIA PHARMACOLOGICA JAPONICA, 1985, 85 (06) : 447 - 451
  • [29] 3-[4-(dimethylamino)phenyl]-2-(4-methoxyphenyl)acrylonitrile
    Kavitha, C. V.
    Sarala, G.
    Rangappa, K. S.
    Sridhar, M. A.
    Prasad, J. Shashidhara
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2006, 62 : O4345 - O4347
  • [30] ANTIHYPERTENSIVE MECHANISMS OF 3-[2-[4-(ORTHO-METHOXYPHENYL)-1-PIPERAZINYL]ETHYL]-2,4(1H,3H)-QUINAZOLINEDIONE MONO HYDROCHLORIDE (SGB-1534)
    AONO, J
    ISHIZUKA, N
    NABATA, H
    SAKAI, K
    JAPANESE JOURNAL OF PHARMACOLOGY, 1984, 36 : P281 - P281
12345